AFP and hepatocellular carcinoma: As expected, Ad-HNF3γ-administered HCC xenografts exhibited a more differentiated phenotype with suppressed AFP, CK19, and CD133 expression and enhanced expression of hepatocyte-specific genes and hepatic differentiation-related molecules (Fig. 6d, e).